Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma Clear Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05460000
What this trial is testing

A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma+1 more
North Eastern German Society of Gynaecological Oncology 640
Testing effectiveness (Phase 2)Study completedNCT00979992
What this trial is testing

Sunitinib Malate in Treating Patients With Persistent or Recurrent Clear Cell Ovarian Cancer

Who this might be right for
Ovarian Clear Cell AdenocarcinomaRecurrent Ovarian Carcinoma
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Ended earlyNCT05949632
What this trial is testing

INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Incyte Corporation 5
Not applicableActive Not RecruitingNCT05782400
What this trial is testing

Multiomics Approach in Metastatic Clear Renal Cell Carcnoma

Who this might be right for
Metastatic Clear Cell Renal Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 100
Testing effectiveness (Phase 2)Ended earlyNCT00176501
What this trial is testing

Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Rutgers, The State University of New Jersey 3
Testing effectiveness (Phase 2)Looking for participantsNCT05665361
What this trial is testing

Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)

Who this might be right for
Advanced Clear Cell Renal Carcinoma (Ccrcc)Papillary Renal Cell Carcinoma (Prcc)
National Cancer Institute (NCI) 100
Early research (Phase 1)WithdrawnNCT04611139
What this trial is testing

Pilot Trial of SP-2577 Plus Pembrolizumab in Select Gynecologic Cancers

Who this might be right for
SCCOHTOvarian Clear Cell TumorOvarian Endometrioid Adenocarcinoma+1 more
HonorHealth Research Institute
Testing effectiveness (Phase 2)Study completedNCT00002538
What this trial is testing

Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group
Early research (Phase 1)Active Not RecruitingNCT02974738
What this trial is testing

A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001)

Who this might be right for
Advanced Solid TumorsSolid TumorSolid Carcinoma+13 more
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 120
Testing effectiveness (Phase 2)Study completedNCT00888615
What this trial is testing

Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous Adenocarcinoma+15 more
GOG Foundation 58
Post-approval studies (Phase 4)Study completedNCT01521715
What this trial is testing

First Line Pazopanib in Poor Risk Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Locally Advanced and/or Metastatic Renal Cell CarcinomaCarcinoma, Renal CellClear-cell Metastatic Renal Cell Carcinoma
iOMEDICO AG 44
Not applicableStudy completedNCT01107509
What this trial is testing

Pilot Study of Neo-Adjuvant Everolimus to Treat Advanced Renal Cell Carcinoma - Analysis of Biomarkers

Who this might be right for
Carcinoma, Renal Cell
St. Joseph's Healthcare Hamilton 20
Early research (Phase 1)Study completedNCT03829111
What this trial is testing

CBM588, Nivolumab, and Ipilimumab in Treating Patients With Stage IV or Advanced Kidney Cancer

Who this might be right for
Advanced Renal Cell CarcinomaClear Cell Renal Cell CarcinomaMetastatic Renal Cell Carcinoma+3 more
City of Hope Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT00563784
What this trial is testing

TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung CancerLung Cancer
M.D. Anderson Cancer Center 68
Early research (Phase 1)Active Not RecruitingNCT02293980
What this trial is testing

A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001)

Who this might be right for
ccRCCRCCKidney Cancer+2 more
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 110
Testing effectiveness (Phase 2)Looking for participantsNCT06065462
What this trial is testing

Safety and Efficacy of Targeting PP2A in Ovarian Clear Cell Carcinoma Using Dostarlimab and LB-100

Who this might be right for
Ovarian Clear Cell Carcinoma
M.D. Anderson Cancer Center 21
Testing effectiveness (Phase 2)UnknownNCT00017303
What this trial is testing

Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal Cavity Cancer
Cytran
Early research (Phase 1)Study completedNCT05585034
What this trial is testing

Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaMelanoma Excluding Uveal MelanomaNon-small Cell Lung Cancer, Squamous or Non-squamous+6 more
Xencor, Inc. 60
Testing effectiveness (Phase 2)UnknownNCT01791387
What this trial is testing

1st-line Activity of Dovitinib and Correlation With Genetic Changes in RCC

Who this might be right for
Clear Cell Renal Cell Carcinoma
Auckland District Health Board 30
Testing effectiveness (Phase 2)Study completedNCT01157091
What this trial is testing

Pazopanib Hydrochloride in Treating Patients With Stage IV Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage IV Renal Cell Cancer
City of Hope Medical Center 28
Next Page